BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE and DRUG WITHDRAWAL SYNDROME

5 reports of this reaction

4.3% of all BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE reports

#4 most reported adverse reaction

Overview

DRUG WITHDRAWAL SYNDROME is the #4 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, manufactured by Accord Healthcare, Inc. There are 5 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE to DRUG WITHDRAWAL SYNDROME. This represents approximately 4.3% of all 116 adverse event reports for this drug.

Patients taking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG WITHDRAWAL SYNDROME5 of 116 reports

DRUG WITHDRAWAL SYNDROME is moderately reported among BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE

In addition to drug withdrawal syndrome, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE:

Other Drugs Associated with DRUG WITHDRAWAL SYNDROME

The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:

BUPIVACAINEBUPRENORPHINEBUPRENORPHINE AND NALOXONEBUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDEDESVENLAFAXINE SUCCINATEDULOXETINE HYDROCHLORIDEFENTANYLHYDROCODONE BITARTRATEHYDROCODONE BITARTRATE AND ACETAMINOPHENHYDROMORPHONE HYDROCHLORIDEMETHADONEMETHADONE HYDROCHLORIDEMORPHINE SULFATENALOXONE HYDROCHLORIDEOXYCODONEOXYCODONE HYDROCHLORIDEPAROXETINE HYDROCHLORIDESALICYLIC ACID 17% WART REMOVER

Frequently Asked Questions

Does BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE cause DRUG WITHDRAWAL SYNDROME?

DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 5 FDA reports for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG WITHDRAWAL SYNDROME with BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE?

DRUG WITHDRAWAL SYNDROME accounts for approximately 4.3% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, making it a notable side effect.

What should I do if I experience DRUG WITHDRAWAL SYNDROME while taking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE?

If you experience drug withdrawal syndrome while taking BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Full ProfileAll Drugs Causing DRUG WITHDRAWAL SYNDROMEAccord Healthcare, Inc Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.